pharma news today glp-1 obesity drugs today biotech Therapies Reshape Future of Healthcare Poll: 1 in 8 Adults

This synthetic peptide is quietly redefining how we think about multi-pathway longevity therapeutics

Available: [Accessed: 16-May-2019]

FDA staff recommends against adding any of these 7 peptides to the 503A Bulks List: BPC-157 (free base/acetate) KPV (free base/acetate) TB-500 (free base/acetate) MOTS-c (free base/acetate) Emideltide/DSIP (free base/acetate) Epitalon (free base/acetate) Semax (free base/acetate) What it means: The 503A Bulks List allows compounding pharmacies to create customized versions for patients with a prescription

In a feeding experiment using Arctic charr fed soybean - , linseed- and marine oils on aerobic gut microbiota before and after challenge with Aeromonas salmonicida ssp